跳至主要内容
临床试验/IRCT201111291414N29
IRCT201111291414N29已完成早期 1 期

Investigation on autologous mesenchymal stem cell transplantation in diabetic retinopathy

The EMRI Endocrinology and Metabolism Research Institute ? Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
All

入选标准

  • People with diabetes type one with at least 10 years duration ;Age 18-40 years;Signing informed consent;Patients with diabetic retinopathy diagnosed by an ophthalmologist ;HbA1c = 7.5% (blood glucose is controlled at least for one month);All eligible patients for celltherapy (according to standard protocol ); BP=130/80 ;Cardiac Consultation form that is filled by a cardiologist (Cardiac echocardiography and ECG)
  • Exclusion criteria: Acute vascular inflammation ; Acute thrombosis (three months); Pulmonary hypertension;Liver disease; Hematological malignancy and bone marrow cancer;Infectious diseases;Mental illness; Generalized edema ; Malignancy; pregnancy ; Sensitivity to the fluorescein

排除标准

  • 未提供

研究者

发起方
The EMRI Endocrinology and Metabolism Research Institute ? Tehran University of Medical Sciences

相似试验

Investigation on autologous mesenchymal stem cell... | 临床试验